Medical University of Vienna
π¦πΉAustria
- Country
- π¦πΉAustria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Treatment of Chronic GVHD of Liver or Lungs by ECP
Phase 2
- Conditions
- Chronic Graft-Versus Host Disease
- First Posted Date
- 2006-01-04
- Last Posted Date
- 2006-01-04
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 20
- Registration Number
- NCT00271869
- Locations
- π¦πΉ
Medical University of Vienna, Department of Medicine I, BMT, Vienna, Austria
Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity
Phase 1
Completed
- Conditions
- Inflammation
- First Posted Date
- 2005-12-12
- Last Posted Date
- 2008-05-22
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 43
- Registration Number
- NCT00264186
- Locations
- π¦πΉ
Medical University of Vienna - General Hospital of the City of Vienna AKH, Vienna, Austria
Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma
Phase 2
- Conditions
- Lymphoma, Mantle-Cell
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2006-10-18
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 16
- Registration Number
- NCT00261612
- Locations
- π¦πΉ
Medical University Vienna, Dept. of Medicine I, Clinical Division of Oncology, Vienna, Austria
Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II
Phase 2
Completed
- Conditions
- Cervical Intraepithelial Neoplasia
- First Posted Date
- 2005-11-01
- Last Posted Date
- 2012-03-09
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 40
- Registration Number
- NCT00247169
- Locations
- π¦πΉ
Dept OB/GYN, Med University of Vienna, Vienna, Austria
The Vienna Prograf and Endothelial Progenitor Cell Study
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-02-05
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 148
- Registration Number
- NCT00182559
- Locations
- π¦πΉ
Medical University of Vienna, Vienna, Austria
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
Phase 2
Completed
- Conditions
- Chronic Heart Failure
- Interventions
- Dietary Supplement: Omacor
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2010-07-13
- Lead Sponsor
- Medical University of Vienna
- Registration Number
- NCT00149409
- Locations
- π¦πΉ
Medical University of Vienna, Vienna, Austria
Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone
Phase 3
- Conditions
- Carcinoma, Hepatocellular
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2005-10-18
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 120
- Registration Number
- NCT00121914
- Locations
- π¦πΉ
Universitaetsklinik fuer Innere Medizin IV / Gastroenterologie und Hepatologie, Vienna, Austria
Β© Copyright 2025. All Rights Reserved by MedPath